Drug Discovery World

JUNE 29, 2023

Kate Woolland, Chief Operating Officer, Closed Loop Medicine Bringing extensive strategic business experience, including over 13 years in healthcare, Kate will play a pivotal role in leading collaboration across the multi-disciplinary team whilst working closely with current and future commercial partners.

Drugs 52

Drugs Gene Therapy Development Clinical Trials 52

pharmaphorum

FEBRUARY 11, 2021

The online event also heard from Pfizer and patient advocate representatives and looked at how the NIHR’s collective approach allows life sciences firms to engage with patients while remaining aligned with ethics guidelines and codes of conduct – providing a UK solution to a global problem.

Clinical Trials 91

Clinical Trials Clinical Trials Trials Clinical Research 91

Drug Discovery World

JUNE 5, 2023

New approaches to partnering In this event in the Biotech track, Clive Cookson, Science Editor at the Financial Times, interviewed John McDonald, Corporate Vice President, Global R&D Business Development, Novo Nordisk. The discussion answered three main questions: What is the new direction for the company?

Genome 52

Genome Genomics Life Science Genetics 52

The Pharma Data

DECEMBER 17, 2020

Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs. Prior to Fulcrum, Cadavid held several leadership positions at Biogen, including Senior Medical Director of the multiple sclerosis clinical development group.

Development 52

Development Gene Therapy Engineer Life Science 52

The Pharma Data

JANUARY 12, 2021

Marianne De Backer, Head of Business Development & Licensing in Bayer’s Pharmaceuticals Division, pictured above. Each of the companies met strict criteria that includes assets in clinical development, an industry-leading platform and in-house manufacturing capabilities. “We Photo courtesy of Bayer.

Gene Therapy 52

Gene Therapy Gene Gene Editing Licensing 52

Pharmaceutical Technology

DECEMBER 22, 2022

The company has partnered with life sciences-focused investors Sixth Street and Royalty Pharma with an aim to bring substantial non-dilutive, low-cost capital to boost innovation and growth.

Insulin 130

Insulin Production Development Genetics 130

The Pharma Data

DECEMBER 8, 2020

December is bringing frost in the North and plenty of cold hard cash for these life sciences companies. . European venture capital firm Forbion rounded up $545 million for its fifth life sciences fund. The rest will be invested in “highly impactful existing companies.” Sigilon Therapeutics .

RNA 52

RNA Antibody Life Science Protein 52

The Pharma Data

NOVEMBER 5, 2020

Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. VectivBio AG – Based in Switzerland, VectivBio named Sarah Holland as chief business officer and Aditya Venugopal as head of business development.

Genome 40

Genome Genomics Medicine Life Science 40

Drug Discovery World

APRIL 29, 2024

Hall has been with the company for more than 16 years, including as Chief Commercial Officer, and was previously Head of Business Development in Europe for Cyprotex. Bironneau brings over two decades of commercial leadership experience, including as Vice President, Global Sales & Business Development at Axplora and Novasep.

Drugs 52

Drugs Sales Gene Therapy Life Science 52

pharmaphorum

DECEMBER 14, 2022

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. It aims to shape companies in the digital healthcare, connected medical devices, and life sciences spaces.

Life Science 105

Life Science Development Business Development Genetics 105

XTalks

AUGUST 2, 2023

They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. 2022 Revenue: In 2022, Merck KGaA (Life Science and Healthcare divisions only) had an annual revenue of €18.22

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Drug Discovery World

SEPTEMBER 16, 2022

Globally, the pipeline for therapies in this sector has continued to grow over the years, and in 2021, there were just under 2,500 cell and gene therapies in some stage of clinical development. . BioMed Realty, a prominent life sciences real estate provider, acquired a 7.5-acre Key comment US . “We

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

The Pharma Data

NOVEMBER 19, 2020

Previously, she was head of Business Development at Cubist Pharmaceuticals. Previously, Baffa was Therapeutic Area Head of Oncology, Global Clinical Development for Shire. At the Bill & Melinda Gates Medical Research Institute, she previously held the role of chief of staff before being appointed special adviser.

Life Science 52

Life Science Research Development Radiology 52

Drug Discovery World

NOVEMBER 13, 2023

Yuchih Lin, Doctor, Sino Biological Europe, on: ‘Accelerating drug discovery using advanced antibody development platforms’. Ellen Hilgenberg, PhD, Senior Business Development Manager, Business Development, ProBioGen, on: ‘DirectedLuck for bispecifics – a transposase system streamlines cell line development’.

Protein 59

Protein Antibody Engineer Scientist 59

The Pharma Data

OCTOBER 15, 2020

The committee is tasked with supporting BeyondSpring’s business development activities related to its lead asset, Plinabulin, and other pipeline assets. Mukul Agarwal, former vice president of Corporate Development, at Forty Seven, Inc., Prior to joining Genalyte, Hanna served as COO at Verily Life Sciences.

In-Vivo 52

In-Vivo Business Development Manufacturing Development 52

The Pharma Data

NOVEMBER 15, 2020

Prior to Celgene, she held leadership roles in marketing, sales and new business development from 2002 to 2011 at Johnson & Johnson. Mr. Shah is a seasoned executive, entrepreneur, and investor with more than 20 years of experience in building life science technology companies. Before that, Ms. About MultiStem ®.

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40

Drug Discovery World

NOVEMBER 30, 2023

Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. This was followed by another presentation in the track, within the session on harnessing neutrophils using bispecifics.

Antibody 59

Antibody Protein Engineer In-Vivo 59

Pharmaceutical Technology

JANUARY 26, 2023

“It is not a miracle, it has come about through a lot of dedicated research, development, exceptional science and very passionate people working together for the benefit of the patient,” explains Alexandra Brownfield, head of business development at Edinburgh-based RoslinCT. Credit: Phil Wilkinson via RoslinCT.

Gene Therapy 130

Gene Therapy Gene Medicine Manufacturing 130